Literature DB >> 16517054

Histologic features in the urinary bladder wall affected from neurogenic overactivity--a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A.

Eva Compérat1, André Reitz, Annick Delcourt, Frederique Capron, Pierre Denys, Emmanuel Chartier-Kastler.   

Abstract

OBJECTIVES: To study histological features and morphological differences in bladder wall specimen from patients with and without botulinum toxin A injections and to compare those issues in responders and non-responders to the toxin therapy.
MATERIAL AND METHODS: Bladder wall specimen obtained from cystectomy in 45 patients with neurogenic overactive bladders with and without injection of botulinum toxin A into the detrusor muscle for treatment of neurogenic incontinence were evaluated concerning the histological criteria inflammation, oedema and fibrosis of the bladder wall.
RESULTS: Bladder wall specimen obtained from patients suffering from neurogenic detrusor overactivity showed important histological alterations. Generally, inflammatory infiltration, oedema and fibrosis of the bladder wall were frequently observed. When comparing specimen from patients who had received botulinum toxin injection to those from patients who had not, there was no difference concerning inflammation and oedema. However, patients who had received botulinum toxin injection showed significantly less fibrosis of the bladder wall than those who had not received the toxin injection (p<0.00073). When comparing specimen from responders and non-responders to the botulinum toxin therapy, there was no difference in inflammation. Although not significant, a trend was observed that responder to the toxin therapy had less fibrosis and oedema of the bladder wall than non-responder.
CONCLUSION: In our study injection of botulinum toxin into the detrusor muscle did not lead to increased fibrotic activity within the bladder wall, on the contrary patients with previous botulinum toxin injection revealed significant less fibrosis than patients without toxin injection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517054     DOI: 10.1016/j.eururo.2006.01.025

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  50 in total

1.  Botulinum toxin and urinary bladder disorders in women: new insight into an old problem.

Authors:  Ervin Kocjancic; Diaa E E Rizk
Journal:  Int Urogynecol J       Date:  2010-04-01       Impact factor: 2.894

Review 2.  Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity.

Authors:  Christopher Dowson; Mohammad Shamim Khan; Prokar Dasgupta; Arun Sahai
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

3.  Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls.

Authors:  Holly E Richter; Pamela Moalli; Cindy L Amundsen; Anna P Malykhina; Dennis Wallace; Rebecca Rogers; Deborah Myers; Maria Paraiso; Michael Albo; Haolin Shi; Tracy Nolen; Susie Meikle; R Ann Word
Journal:  J Urol       Date:  2017-01-13       Impact factor: 7.450

4.  A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging.

Authors:  Ulrich Mehnert; Sönke Boy; Marius Schmid; André Reitz; Alexander von Hessling; Juerg Hodler; Brigitte Schurch
Journal:  World J Urol       Date:  2009-01-15       Impact factor: 4.226

Review 5.  Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review.

Authors:  Todd A Linsenmeyer
Journal:  J Spinal Cord Med       Date:  2013-09       Impact factor: 1.985

Review 6.  Medium- to long-term outcomes of botulinum toxin A for idiopathic overactive bladder.

Authors:  David Eldred-Evans; Arun Sahai
Journal:  Ther Adv Urol       Date:  2016-10-19

7.  Botulinum toxin in neurogenic detrusor overactivity.

Authors:  Carlos Arturo Levi D'Ancona; Rúiter Silva Ferreira; Mauricio Carneiro Rassi
Journal:  Int Neurourol J       Date:  2012-09-30       Impact factor: 2.835

8.  Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study.

Authors:  Pradeep Tyagi; Derek Barclay; Ruben Zamora; Naoki Yoshimura; Kenneth Peters; Yoram Vodovotz; Michael Chancellor
Journal:  Int Urol Nephrol       Date:  2009-09-26       Impact factor: 2.370

9.  Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity.

Authors:  Ibrahim Fathi Ghalayini; Mohammed A Al-Ghazo; Ziad Ali Elnasser
Journal:  Int Urol Nephrol       Date:  2009-01-31       Impact factor: 2.370

10.  Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive bladder.

Authors:  Brian L Cohen; Daniel J Caruso; Prashanth Kanagarajah; Angelo E Gousse
Journal:  Adv Urol       Date:  2009-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.